Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses.
暂无分享,去创建一个
Jonathan B. Mitchem | S. Hewitt | C. Wegner | D. Piwnica-Worms | D. Brennan | W. Gallagher | D. Sanford | D. Linehan | D. DeNardo | P. Goedegebuure | B. West | Yu Zhu | Brett L. Knolhoff | D. Carpenter | B. Belt | A. Wang-Gillam | J. Mitchem | Larisa Belaygorod | L. Collins | G. M. Udupi | Brett L Knolhoff | Lynne I Collins
[1] N. Jhala,et al. Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer. , 2012, Cancer cell.
[2] D. Bar-Sagi,et al. Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia. , 2012, Cancer cell.
[3] Jae-Hyun Park,et al. Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistance. , 2012, Cancer cell.
[4] D. Gabrilovich,et al. Coordinated regulation of myeloid cells by tumours , 2012, Nature Reviews Immunology.
[5] Mikala Egeblad,et al. Marginating dendritic cells of the tumor microenvironment cross-present tumor antigens and stably engage tumor-specific T cells. , 2012, Cancer cell.
[6] V. Gocheva,et al. Deficiency of the macrophage growth factor CSF-1 disrupts pancreatic neuroendocrine tumor development , 2012, Oncogene.
[7] Hong Peng,et al. Interactions between cancer stem cells and their niche govern metastatic colonization , 2011, Nature.
[8] E. Brogi,et al. Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer. , 2011, Genes & development.
[9] P. Carmeliet,et al. A vascular niche and a VEGF–Nrp1 loop regulate the initiation and stemness of skin tumours , 2011, Nature.
[10] Lixin Shao,et al. Discovery of INCB8761/PF-4136309, a Potent, Selective, and Orally Bioavailable CCR2 Antagonist. , 2011, ACS medicinal chemistry letters.
[11] Daniel G. Anderson,et al. Therapeutic siRNA silencing in inflammatory monocytes , 2011, Nature Biotechnology.
[12] D. Levy,et al. STAT3 plays a critical role in KRAS-induced pancreatic tumorigenesis. , 2011, Cancer research.
[13] Hideaki Tahara,et al. Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem/initiating cells , 2011, Proceedings of the National Academy of Sciences.
[14] M. Wicha,et al. Regulation of Cancer Stem Cells by Cytokine Networks: Attacking Cancer's Inflammatory Roots , 2011, Clinical Cancer Research.
[15] Jinghang Zhang,et al. CCL2 recruits inflammatory monocytes to facilitate breast tumor metastasis , 2011, Nature.
[16] Karin Jirström,et al. Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy. , 2011, Cancer discovery.
[17] S. Gendler,et al. Pancreatic ductal adenocarcinoma mice lacking mucin 1 have a profound defect in tumor growth and metastasis. , 2011, Cancer research.
[18] S. Akira,et al. Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression. , 2011, Cancer cell.
[19] P. Spellman,et al. Subtypes of Pancreatic Ductal Adenocarcinoma and Their Differing Responses to Therapy , 2011, Nature Medicine.
[20] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[21] Ling Xia,et al. Cancer stem cell, niche and EGFR decide tumor development and treatment response: A bio-computational simulation study. , 2011, Journal of theoretical biology.
[22] M. Wicha,et al. Endothelial cell-initiated signaling promotes the survival and self-renewal of cancer stem cells. , 2010, Cancer research.
[23] S. Gendler,et al. MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition , 2010, Oncogene.
[24] J. Reis-Filho,et al. Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment , 2010, Breast Cancer Research and Treatment.
[25] Louis Vermeulen,et al. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment , 2010, Nature Cell Biology.
[26] Jeffrey W. Pollard,et al. Macrophage Diversity Enhances Tumor Progression and Metastasis , 2010, Cell.
[27] M. Karin,et al. Immunity, Inflammation, and Cancer , 2010, Cell.
[28] J. Joyce,et al. IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion. , 2010, Genes & development.
[29] H. Colman,et al. Glioma-Associated Cancer-Initiating Cells Induce Immunosuppression , 2010, Clinical Cancer Research.
[30] F. Bertucci,et al. Aldehyde Dehydrogenase 1–Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer , 2009, Clinical Cancer Research.
[31] B. Cochran,et al. STAT3 Is Required for Proliferation and Maintenance of Multipotency in Glioblastoma Stem Cells , 2009, Stem cells.
[32] Na Zhang,et al. Deletion of Vascular Endothelial Growth Factor in myeloid cells accelerates tumorigenesis , 2008, Nature.
[33] William M Gallagher,et al. Novel image analysis approach for quantifying expression of nuclear proteins assessed by immunohistochemistry: application to measurement of oestrogen and progesterone receptor levels in breast cancer , 2008, Breast Cancer Research.
[34] M. Krause,et al. Exploring the role of cancer stem cells in radioresistance , 2008, Nature Reviews Cancer.
[35] Kam Y. J. Zhang,et al. Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity , 2008, Proceedings of the National Academy of Sciences.
[36] Lloyd J. Old,et al. Adaptive immunity maintains occult cancer in an equilibrium state , 2007, Nature.
[37] F. Peale,et al. Bv8 regulates myeloid-cell-dependent tumour angiogenesis , 2007, Nature.
[38] J. Margolick,et al. Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance , 2007, Proceedings of the National Academy of Sciences.
[39] Mark R Player,et al. Crystal Structure of the Tyrosine Kinase Domain of Colony-stimulating Factor-1 Receptor (cFMS) in Complex with Two Inhibitors* , 2006, Journal of Biological Chemistry.
[40] Bianca Sperl,et al. Stattic: a small-molecule inhibitor of STAT3 activation and dimerization. , 2006, Chemistry & biology.
[41] J. Parham,et al. Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[42] David Piwnica-Worms,et al. Real-time imaging of ligand-induced IKK activation in intact cells and in living mice , 2005, Nature Methods.
[43] R. DePinho,et al. Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. , 2003, Genes & development.
[44] Andrew V. Nguyen,et al. The Macrophage Growth Factor CSF-1 in Mammary Gland Development and Tumor Progression , 2002, Journal of Mammary Gland Biology and Neoplasia.
[45] F. Schabel,et al. Induction and chemotherapeutic response of two transplantable ductal adenocarcinomas of the pancreas in C57BL/6 mice. , 1984, Cancer research.
[46] Douglas B. Evans,et al. Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice , 2009, Nature Protocols.